Congratulations to Dr Effie Polyzogopoulou on Receiving the EUSEM Fellowship

The European Society for Emergency Medicine (EUSEM) is delighted to congratulate Dr Effie Polyzogopoulou, Chair of the EUSEM Ultrasound Section and Associate Professor of Emergency Medicine at the National and Kapodistrian University of Athens, on being awarded the prestigious EUSEM Fellowship.

This distinction recognises Dr Polyzogopoulou’s outstanding contributions to emergency medicine, her dedication to advancing point-of-care ultrasound, and her commitment to education, research, and professional development within the European emergency medicine community.

Over the years, Dr Polyzogopoulou has played a leading role in promoting the integration of ultrasound into everyday emergency care, helping to enhance diagnostic accuracy, patient safety, and clinical decision-making. Through her leadership of the EUSEM Ultrasound Section, she has been instrumental in fostering collaboration, supporting educational initiatives, and advancing the dissemination of ultrasound knowledge across Europe.

As an Associate Professor of Emergency Medicine at the National and Kapodistrian University of Athens, she has demonstrated an unwavering commitment to training the next generation of emergency physicians while contributing significantly to academic research and innovation in the field.

The award of EUSEM Fellowship is a well-deserved recognition of her professional excellence, leadership, and sustained service to emergency medicine. Her achievements continue to inspire colleagues and trainees alike, and her work has had a lasting impact on the growth and development of emergency medicine both nationally and internationally.

On behalf of the EUSEM community, we extend our warmest congratulations to Dr Polyzogopoulou on this remarkable achievement and wish her continued success in her future endeavours.

Congratulations, Dr Effie Polyzogopoulou, on becoming a EUSEM Fellow!

Read more...

EUSEM Leadership Team Re-Elected to Continue Driving the Society Forward

The European Society for Emergency Medicine (EUSEM) is delighted to announce the re-election of three highly valued members of its Executive Committee, reflecting the confidence of the membership in their leadership and dedication to advancing emergency medicine across Europe.

We warmly congratulate:

  • Dr Niccolò Parri on his re-election as Vice President
  • Dr Tatjana Rajkovic on her re-election as Honorary Secretary
  • Prof. Diana Cimpoeșu on her re-election as Honorary Treasurer

Their re-election ensures continuity within the EUSEM leadership team at an important time for the Society, as it continues to expand its educational activities, strengthen its advocacy efforts, support emergency physicians across Europe, and prepare the specialty for future challenges.

Over the past years, all three officers have made significant contributions to EUSEM's growth and development. Their commitment, expertise, and collaborative spirit have helped strengthen the Society's governance, support its members, and advance the mission of promoting excellence in emergency medicine throughout Europe.

Together with newly elected President Professor Christoph Dodt, the re-elected officers will help guide EUSEM through the next chapter of its development. The leadership team is united in its commitment to fostering innovation, supporting the next generation of emergency physicians, promoting gender balance and inclusivity, and ensuring that EUSEM remains the leading European forum for education, research, collaboration, and professional development in emergency medicine.

On behalf of the entire EUSEM community, we extend our sincere congratulations to Dr Niccolò Parri, Dr Tatjana Rajkovic, and Prof. Diana Cimpoeșu, and we look forward to their continued leadership and service in the years ahead.

Congratulations and thank you for your ongoing dedication to EUSEM and the emergency medicine community across Europe.

Read more...

Press release: Nasal spray brings pain relief for children treated in the emergency department

Paris, France: A treatment for pain, that is delivered via a nasal spray, offers an effective, needle-free option for children being seen in the emergency department for a range of injuries, according to research presented at the European Emergency Medicine Congress today (Sunday) [1].

Researchers say that reducing pain quickly and effectively is especially important for children in the emergency department, yet there are currently very few treatment options available.

The research was presented by Professor Shammi Ramlakhan, an emergency medicine consultant working at Sheffield Children's Hospital, the University of Sheffield and Sheffield Hallam University in the UK.

He said: “Pain in children remains under-recognised and under-treated. Nearly a third of children with moderate to severe pain do not receive adequate pain relief within the 15 to 20 minutes recommended in international guidance. In this study we explored whether a combination of analgesic medication given in a simple dosing system would help provide quick and effective pain relief for children being treated in the emergency department.”

The research included 152 children aged between one and 17 with moderate to severe pain who were being treated at one of seven hospital emergency departments in the UK and Spain between May 2024 and May 2025 [2]. The majority had limb injuries, such as fractures and dislocations, while other children had burns or soft tissue injuries.

All children were given a combination of two pain relief medications, sufentanil and ketamine, via a nasal spray. The dose was adjusted according to the weight of each child by the number of puffs of the nasal spray. Children were assessed 15 minutes after being given the treatment and again after 30 minutes. The researchers used standard assessments to check how much pain children were in and to look for any side effects of the treatment.

After 15 minutes, more than half of the children (54%) were in less pain and after 30 minutes most of the children (88%) children were in less pain. Pain was reduced by around half in the majority of children (86.2%) 30 minutes after treatment. Side effects were mild and included nausea or vomiting, dizziness and nasal itching

Professor Ramlakhan said: “Our research shows that this drug can provide rapid and meaningful pain relief for children being treated in the emergency department. Children tolerated the nose spray well with no major side effects. This is good news for children and their families. This also gives doctors a simple and effective option for treating their patients where very few options currently exist.”

The nasal spray was being tested for the European Medicines Agency (EMA)’s paediatric-use marketing authorisation (PUMA) scheme, which aims to encourage manufacturers to develop and

adapt medications specifically for children. Researchers say the treatment should be available for use in Europe in the near future.

Dr Maša Sorić is a member of the EUSEM abstract selection committee. She is head of the emergency department at University Hospital Merkur, Zagreb, Croatia, and was not involved with the research. She said: “Across Europe, we see millions of children in the emergency department every year. Many of these will be suffering painful injuries. Being in hospital can also be frightening for children and their families.

“This study assesses a nasal spray containing two existing types of pain relief with a very simple dosing system. The results suggest it helps to reduce pain quickly and effectively, without the need for an injection. The treatment did not cause too much drowsiness, and the side effects were mild.

“As doctors we want to give our patients effective treatments, and that includes treatment to reduce any pain they are suffering. However, the pain relief options that are currently available for children are limited at the moment, so we really need more treatments like this in the emergency department.”

(ends)

[1] Abstract no: OA099, “Efficacy, Safety and Satisfaction of a Fixed-dose Combination of Intranasal Sufentanil-ketamine (in SUF/kKET) in the Treatment of Acute Pain in Children in the Emergency Department” by Shammi Ramlakhan, Pain Management abstracts session, Sunday 27 September, 14.00-15.30 hrs CEST, Room 152.

[2] Sheffield Children’s Hospital; Birmingham Women's and Children's NHS Foundation Trust, and Royal London Hospital in the UK; and Hospital General Universitario Dr. Balmis, Alicante; Hospital Sant Joan de Deu, Barcelona; Universidad Autonoma de Madrid - Hospital Universitario La Paz (HULP), Madrid; and Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, in Spain.

Funding: This study was funded by Cessatech.

Read more...

Press Release: Blood test shows whether newborns with fever have bacterial or viral infection

Press Release: Blood test shows whether newborns with fever have bacterial or viral infection

Paris, France: A test that compares the levels of two molecules in the blood is able to accurately distinguish between bacterial and viral infections in newborn babies with fever in a small study presented at the European Emergency Medicine Congress today (Sunday) [1].

A fever in a baby under three months of age is considered a medical emergency, because in very young babies with undeveloped immune systems, an infection can quickly become life threatening.

However, in the emergency department, staff need to assess babies with fever to distinguish the most serious bacterial infections that require antibiotics from viral infection that typically pass with monitoring and care.

The new research was presented by Dr Tommaso Bellini, a paediatric emergency physician at the IRCCS Istituto Giannina Gaslini in Genoa, Italy. He said: “In very young babies with fever, distinguishing serious bacterial infection from self-limiting viral illness is a major diagnostic dilemma. Our standard biomarkers can help show when there might be a bacterial infection, but they also create ‘false positives’, which drives overtreatment. This can mean unnecessary lumbar punctures, antibiotics, and hospital admissions for infants who turn out to have only a virus.”

The research involved 60 babies who were brought to the paediatric emergency department of IRCCS Istituto Giannina Gaslini. Some were being assessed and treated for fever, while others were being assessed and treated for other, non-infectious conditions.

Dr Bellini and his colleagues collected blood samples from all the babies. They tested the blood samples with flow cytometry – an advanced technique that allows researchers to study the characteristics of individual cells.

They used this technique to quantify the levels of two molecules that are known to increase in response to infections. One of these, called CD64, is found on the surface of neutrophils, a type of white blood cell, and is thought to increase in response to bacterial infection. The other, called CD169, is found on the surface of another type of white blood cell, called a monocyte, and is thought to increase in response to a viral infection.

The researchers combined measurements of both these molecules into a ratio for each baby. A ratio is a simple way of comparing the amount of one thing with the amount of another. They found that this ratio could accurately distinguish between babies with no infection (average ratio score of 1.10), babies who were ultimately confirmed to have a viral infection (average 0.33) and babies confirmed to have a bacterial infection (average 16.22).

The test had a ‘sensitivity’ of 100%, meaning it correctly picked up all the cases of bacterial infection and a ‘specificity’ of 96.6%, meaning that the rate of ‘false positives’ (where the test suggested a baby had a bacterial infection when they did not) was extremely low.

Dr Bellini said: “These two marker molecules show opposite signatures – during a viral infection one is high while the other is low, and during a bacterial infection the reverse is true. Combining them into a single ratio separated bacterial from non-bacterial infection with very high accuracy in our initial cohort of 60 babies.

“This assessment is currently run on flow cytometry, which needs specialised equipment and trained staff. It is not yet a bedside test, and not widely available outside of specialist labs. Translating it into a fast, low-cost, point-of-care format is our next research goal.”

The research is continuing and will ultimately include data on 75 babies. Dr Bellini and his colleagues are also beginning a larger study called DISCERN (Discriminating Infection via Surface CD-marker Expression Ratios iN infancy). This is a multicentre, prospective study assessing the accuracy of the test in 300 to 500 babies.

Dr Maša Sorić is a member of the EUSEM abstract selection committee. She is head of the emergency department at University Hospital Merkur, Zagreb, Croatia, and was not involved with the research. She said: “For parents, taking a very young baby with a fever into the emergency department can be a very worrying time. We have to treat every case as potentially serious until we know otherwise. At the moment, this can mean invasive tests, treatment with antibiotics and spending a long time in hospital. This is a small study, but the findings are very positive. If these results can be reinforced in a larger trial, they could mean that we have a much better way of knowing which babies probably have a bacterial infection that needs antibiotics, and which babies probably do not. This could ultimately improve treatment and reduce the need for unnecessary treatment.

“There is also a broader issue with bacteria becoming resistant to antibiotics, partly as a result of over-use of these treatments. If we can ensure we only use antibiotics when they are needed, we may also reduce the growth of antibiotic resistance, helping to maintain the effectiveness of these vital medicines.”

(ends)

[1] Abstract no: OA091, “CD64 and CD169 as Translational Biomarkers for Early Bacterial-viral Discrimination in Febrile Infants ≤90 Days” by Tommaso Bellini, Oral abstract session: Paediatric abstracts session, Sunday 27 September, 11.00-12.30 hrs CEST, Room 142.

Funding: No external funding. The study was conducted as part of Dr Bellinin’s doctoral research at the University of Genova (DINOGMI).

Read more...

Press Release: Virtual reality and classical music help to reduce blood pressure in patients in an emergency department

Paris, France: A virtual reality landscape of a flowing river and trees, accompanied by classical music, can help to reduce patients’ blood pressure significantly within 15 minutes of their being seen in an emergency department.

In a randomised controlled trial of 130 adult patients who arrived in an emergency department with hypertensive urgency – blood pressure that is significantly high but without any symptoms or signs indicating acute organ damage – researchers found that viewing natural landscapes with a virtual reality (VR) headset while listening to the soothing music of composers such as Bach, Mozart, Debussy, Vivaldi and Tchaikovsky also reduced patients’ anxiety. The research was presented at the European Emergency Medicine Congress today (Saturday) [1].

Speaking before the congress, the first author and principle investigator of the study, Dr Safa Dönmez, an associate professor of emergency medicine at the University of Health Sciences, Ankara City Health Application and Research Center, Ankara, Turkey, said that as far as he knew, this was the first study to investigate combining VR and classical music to help patients with severely elevated blood pressure in emergency departments.

“Patients who arrive in the emergency department with markedly elevated blood pressure — readings of 180 mmHg or higher on the top number, or 110 mmHg or higher on the bottom number — are extremely common. We treat them with blood pressure medication, but what I kept noticing was how anxious and frightened many of these patients are. That matters medically, not just emotionally, because anxiety causes the body to release stress hormones that tighten the blood vessels and push blood pressure even higher. The emergency department environment itself — the noise, the bright lights, the uncertainty — can make that worse. This made me wonder: if we could help patients feel calmer, could we also help their blood pressure come down faster?” he said.

Dr Dönmez and colleagues, including Dr Kadir Yenal, an emergency medicine specialist at Ankara Bilkent City Hospital, Ankara, randomised patients with hypertensive urgency into an intervention group (65 patients) and a control group (65 patients). All patients received standard medication to reduce blood pressure. Patients in the control group had no other intervention, but the patients in the intervention group put on VR headsets, similar to those used in gaming, that transported them to a peaceful nature scene showing a river flowing through a forest, tall trees and a wooden suspension bridge [2].

At the same time, these patients listened on a smartphone to a playlist of classical music that the researchers had selected because of the calming, structured qualities of music by the composers mentioned above, as well as others such as Saint-Saens, Hadyn and Corelli [3].

The researchers measured the patients’ blood pressure at 15, 30, 60, 90 and 120 minutes. They looked at the mean arterial pressure (MAP), which combines the top (systolic) number with the bottom (diastolic) number to give a single figure representing the average pressure in the arteries during one heartbeat. A normal MAP is roughly 70–100 millimetres of mercury (mmHg). The patients in this study arrived in the emergency department with much higher MAP readings of around 130–138 mmHg.

Researchers assessed anxiety levels using a questionnaire called the State Anxiety Inventory (STAI). STAI-I measures how anxious a patient feels in that moment, which is called “state anxiety”. STAI-II measures how anxious the patient tends to be as a general personality trait and this is called “trait anxiety”. Both are scored from 20 to 80, where higher numbers mean more anxiety.

Even though the patients were randomly assigned to the two groups, the researchers found that those in the VR group had slightly lower blood pressure when they started in the study. To account for this, the researchers not only compared the blood pressure readings between the two groups at all the time points, but also analysed the size of the reduction.

At 15 and 30 minutes, MAP values in the control group fell from 138 mmHg to 126 mmHg and then 119 mmHg, respectively. In the VR group, the MAP values fell from 132 mmHg to 116 mmHg and 112 mmHg, respectively. After 30 minutes there was no longer a significant difference between the groups. At 15 and 30 minutes, the percentage reductions in MAP in the control group were 8% and 14%, respectively, whereas the VR group had greater percentage reductions of 12% and 15%, respectively.

Dr Yenal told the congress: “After 15 minutes, patients in the VR group had both a lower absolute blood pressure reading and a greater reduction from their starting point, compared to the control group. This was a statistically significant finding, meaning it was unlikely to be due to chance. The VR group’s blood pressure dropped approximately 4–5 mmHg more than the control group. After that, the gap then narrowed, and from 60 minutes onwards the two groups were essentially equivalent.”

At the beginning, the VR patients were significantly more anxious than the control group with trait anxiety scores (STAI-II) of about 46 compared to about 38 in the control group. During the observation period, there was a statistically significant difference in the reduction in trait anxiety between the two groups: an average reduction of eight points in the VR group versus four points in the control group.

Dr Yenal said: “By the end of the two-hour observation, both groups had reached similar post-intervention anxiety levels, but the VR group got there from a higher starting point of anxious temperament, which makes their greater improvement all the more notable.”

He said more research should be carried out in larger groups in several other hospitals but, as the technology was inexpensive and easy to use, without any side effects, “I believe it can reasonably be considered as a supportive, patient-centred addition to standard care, especially for patients who are visibly anxious or distressed.”

Dr Dönmez said the study provided early, meaningful evidence that the approach was safe, feasible and beneficial in reducing anxiety and blood pressure.

“The suggestion of faster early blood pressure reduction in the first 15 minutes is clinically interesting. In a busy emergency department, getting blood pressure under control quickly is important — both for patient safety and for the efficient use of resources. If a non-drug intervention can accelerate that process even modestly, it has practical value,” he said. “However, the diminishing effect over time suggests that intervention supports early stabilisation rather than long-term control of blood pressure.

“For patients, the significance of the study is that if you were brought into an emergency department with markedly elevated blood pressure, frightened and in pain, then being offered a few minutes in a peaceful virtual forest while listening to Mozart would likely be welcomed.”

Strengths of the study are that it was a randomised controlled trial that used the same standardised equipment for measuring blood pressure in both groups, and no patient dropped out of the study. Limitations include the difference in average blood pressures between the two groups at the start of the study; it was a single centre study; follow-up was only for two hours; the VR headset and music were always used together so it was not possible to determine which was responsible for the observed effects, or whether both were needed; and patients and medical staff could see who was using the VR headsets, so there could be a placebo effect.

The researchers now plan to conduct further studies in more hospitals with longer follow-up, looking at the effects of VR and classical music separately, and also investigating whether enabling patients to choose their own music makes any difference.

Dr Felix Lorang is a member of the EUSEM abstract selection committee. He is head of the emergency department at Klinikum Lippe, North Rhine-Westfalia,Germany, and was not involved with the research. He said: “Although this is a single-centre study, the results are interesting and deserve further investigation. They raise the possibility that this approach is not only safe and feasible, but offers meaningful benefits, particularly in reducing anxiety and helping to achieve faster blood pressure control during the early stages of treatment, and might avoid unnecessary medication. It is important to note that this approach was used in addition to, and not instead of, adaptation of the medication to reduce blood pressure.”(ends)

[1] Abstract no: OA071, “Effects of virtual reality and classical music therapy on early hemodynamics and anxiety in hypertensive urgency: a randomized controlled study” by Safa Dönmez, Kadir Yenal et al. Best abstracts session, Saturday 26 September, 11:00-12:30 hrs CEST, room 142.

[2] The VR video can be viewed here: [https://youtu.be/Kv5ap7VXjys]

[3] The classical music playlist is here: [https://youtu.be/uk-DSogtQRo]

Funding: The study received no external funding.

Copyright © 2026 EUSEM All Rights Reserved | Privacy policy | Terms & conditions

Read more...

PRESS RELEASE: Drones could speed up delivery of automated external defibrillators to patients suffering cardiac arrest

Paris, France: Drones could be used to deliver automated external defibrillators (AEDs) to where a person is suffering an out-of-hospital cardiac arrest, according to a study presented at the European Emergency Medicine Congress today (Saturday).

AEDs can often be located some distances apart, making timely access to them uneven, particularly in rural areas or in heavily congested urban environments. However, the research presented today showed that delivering AEDs by drone, combined with providing more fixed AEDs, significantly reduced the time between an out-of-hospital cardiac arrest (OHCA) being reported and the start of defibrillation.

“Out-of-hospital cardiac arrest is a major public health issue. Survival depends strongly on early cardiopulmonary resuscitation and timely defibrillation,” Dr Hillary Minka, an emergency physician at the Lariboisière Hospital in Paris, told the congress. “Every minute of delay before defibrillation reduces the chances of survival.

“We wanted to investigate whether drones could provide faster AED access than road-based retrieval of existing fixed AEDs and thereby improve access to defibrillation across the Ile-de-France region.”

Dr Minka and her colleagues used data on OHCAs in seven departments (administrative areas) in the Île-de-France, excluding central Paris, to conduct a computer simulation study that looked at three strategies:

  • Strengthening the current network of fixed AEDs
  • Using drones to deliver AEDs
  • Combining fixed AEDs with drones.

They divided the region into units called Ilots Regroupés pour l’Information Statistique (IRIS), which are the smallest census areas used by the French National Institute of Statistics. They estimated the amount of time needed for an AED to arrive at the centre of each unit via each of the three strategies. They also evaluated several potential locations for drone deployment, including existing AED sites, mobile intensive care units (MICUs) and fire stations.

They found that access to AEDs was very mixed, with a scarcity in the countryside and in the areas on the outskirts of Paris. To improve access to fixed AEDs, a further 1,712 AEDs would need to be added to 1,893 existing AEDs, making a total of 3,605.

Using drones significantly reduced the time spent waiting for access to an AED. The researchers found this depended both on the number of drones deployed and their geographical positioning.

In the hybrid strategy combining fixed AEDs and drones, AED access times were reduced by an average of 3.76 minutes across all IRIS units. AEDs were delivered to more than 95% of OHCA cases within five minutes, compared to only 30-40% of cases when relying on transport from existing fixed AED locations via the road network. The researchers estimated that using 200 drone bases and 871 fixed AED sites could extend AED coverage to nearly all OHCAs (28,349 cases), achieving an overall coverage rate of 99.4%.

Dr Minka said: “Our study showed that drone delivery of AEDs could reduce the times to defibrillation across all the IRIS units by several minutes, with particularly large benefits in peripheral and highly congested areas. In some cases, the time saved exceeded ten minutes.

“Our findings also suggest that this hybrid strategy could provide very broad territorial coverage while limiting the need to install hundreds of additional AEDs. This would increase the range to 3,900 metres, compared to 500 metres for fixed AEDs only.”

The researchers envisage that the drones could be operated by specially trained people or automated systems under the supervision of emergency services. When the drone arrives at the scene of an OHCA, a bystander who is already present would collect the AED and start to use it on the patient, guided by the emergency services.

“Drones will never replace bystanders, resuscitation efforts or emergency medical teams,” said Dr Minka. “However, they could represent an additional link in the chain of survival and help make defibrillation available more quickly. This study also shows that improving access to AEDs depends not only on the number of devices available, but also on how they are geographically distributed and organised. In some areas, drones could therefore represent a complementary strategy to large-scale deployment of additional fixed AEDs.”

She said the study’s findings would need to be confirmed in prospective studies and real-world experiments.

“Our findings highlight the potential value of investing in innovative solutions aimed at reducing inequalities in access to emergency care and optimising the geographical distribution of emergency resources,” she concluded.

A strength of the study is that it analysed seven departments of the Île-de-France region using a detailed geospatial approach based on real-world cardiac arrest data. A limitation is that it is a simulation study, no drones were deployed and so their performance is based on theoretical models. The drone travel time was estimated using straight line distances (“as the crow flies”) and, therefore, did not account for regulatory, meteorological or operational constraints that could influence real-world deployment.

Dr Felix Lorang is a member of the EUSEM abstract selection committee. He is head of the emergency department at Klinikum Lippe, North Rhine-Westfalia,Germany, and was not involved with the research. He said: “Drones are being used for an increasingly wide range of purposes and this study shows how they could make an important contribution to the emergency services, enabling AEDs to reach people suffering heart attacks more quickly. However, it is vitally important that, in every country, as many members of the public as possible know how to provide cardiopulmonary resuscitation and how to use defibrillators. Without this training, someone suffering an out-of-hospital cardiac arrest would still have to wait for the arrival of the emergency services, even if an AED is positioned nearby or arrives quickly by drone.”(ends)

[1] Abstract no: OA066, “Optimizing automated external defibrillator access using drones: a geospatial analysis in the Paris region” by Hillary Minka, Best abstracts session, Saturday 26 September, 11:00-12:30 hrs CEST, room 142.

Funding: This study received no funding.

Read more...